文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

鉴定和评价具有生物活性的天然产物作为人类微管亲和调节激酶 4(MARK4)潜在抑制剂的研究。

Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).

机构信息

a Centre for Interdisciplinary Research in Basic Sciences , Jamia Millia Islamia , Jamia Nagar, New Delhi , 110025 , India.

b Computational Mechanistic Chemistry and Drug Discovery , Rhodes University , Grahamstown , South Africa.

出版信息

J Biomol Struct Dyn. 2019 Apr;37(7):1813-1829. doi: 10.1080/07391102.2018.1468282. Epub 2018 May 24.


DOI:10.1080/07391102.2018.1468282
PMID:29683402
Abstract

Microtubule affinity-regulating kinase 4 (MARK4) has recently been identified as a potential drug target for several complex diseases including cancer, diabetes and neurodegenerative disorders. Inhibition of MARK4 activity is an appealing therapeutic option to treat such diseases. Here, we have performed structure-based virtual high-throughput screening of 100,000 naturally occurring compounds from ZINC database against MARK4 to find its potential inhibitors. The resulted hits were selected, based on the binding affinities, docking scores and selectivity. Further, binding energy calculation, Lipinski filtration and ADMET prediction were carried out to find safe and better hits against MARK4. Best 10 compounds bearing high specificity and binding efficiency were selected, and their binding pattern to MARK4 was analyzed in detail. Finally, 100 ns molecular dynamics simulation was performed to evaluate; the dynamics stability of MARK4-compound complex. In conclusion, these selected natural compounds from ZINC database might be potential leads against MARK4, and can further be exploited in drug design and development for associated diseases.

摘要

微管亲和调节激酶 4(MARK4)最近被确定为几种复杂疾病(包括癌症、糖尿病和神经退行性疾病)的潜在药物靶点。抑制 MARK4 的活性是治疗此类疾病的一种有吸引力的治疗选择。在这里,我们针对 MARK4 对 ZINC 数据库中的 100,000 种天然化合物进行了基于结构的虚拟高通量筛选,以寻找其潜在的抑制剂。根据结合亲和力、对接评分和选择性选择命中结果。此外,进行结合能计算、Lipinski 过滤和 ADMET 预测,以找到针对 MARK4 的安全且更好的命中结果。选择了 10 个具有高特异性和结合效率的最佳化合物,并详细分析了它们与 MARK4 的结合模式。最后,进行了 100ns 分子动力学模拟,以评估 MARK4-化合物复合物的动力学稳定性。总之,这些来自 ZINC 数据库的天然化合物可能是针对 MARK4 的潜在先导化合物,并可进一步用于相关疾病的药物设计和开发。

相似文献

[1]
Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).

J Biomol Struct Dyn. 2018-5-24

[2]
Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.

OMICS. 2015-11

[3]
Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.

J Biomol Struct Dyn. 2016-11-3

[4]
PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.

J Mol Graph Model. 2015-11

[5]
Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.

J Cell Biochem. 2021-10

[6]
Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.

J Biomol Struct Dyn. 2019-2-21

[7]
Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.

Molecules. 2020-2-13

[8]
Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.

J Mol Recognit. 2024-1

[9]
MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.

Int J Mol Sci. 2021-10-12

[10]
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.

Int J Biol Macromol. 2020-10-15

引用本文的文献

[1]
Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1.

3 Biotech. 2025-6

[2]
Structure-guided screening identified bioactive phytoconstituents Hernandonine and Anolobine as potential inhibitors of dual specificity protein kinase CLK1.

Sci Rep. 2025-4-19

[3]
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics.

PLoS One. 2025-1-24

[4]
Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents-challenges and limitations.

Discov Oncol. 2024-12-21

[5]
Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.

ACS Omega. 2024-6-5

[6]
Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease.

Front Pharmacol. 2023-9-19

[7]
Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer's therapeutics employing molecular docking and dynamics simulation.

Mol Divers. 2024-10

[8]
Targeting Filamenting temperature-sensitive mutant Z (FtsZ) with bioactive phytoconstituents: An emerging strategy for antibacterial therapy.

PLoS One. 2023

[9]
Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism.

Int J Mol Sci. 2023-5-6

[10]
Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.

Int J Mol Sci. 2022-10-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索